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Abstract
Background: Seasonal influenza and influenza-like illnesses are widespread, with an impact on GP 
consultations. GPs apply many preventive and protective measures to prevent seasonal influenza 
transmission, with no clear evidence of their effectiveness in this setting.
Aim: To review the effectiveness of preventive and protective measures to reduce the transmission of 
seasonal influenza and influenza-like illnesses in GP practices.
Design & setting: A systematic review was conducted of the literature in Medline, Embase, and the 
Cochrane Central Register databases published between January 1960 and April 2014, later extended 
to January 2018.
Method: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria were 
used. Controlled trials and experimental studies were included. Study quality was assessed according 
to the Cochrane risk of bias tool.
Results: Out of 5727 articles screened, only two studies were finally retained: one study about the 
seasonal influenza vaccination of GPs to prevent transmission from patients or staff, and one about 
surface disinfection. The first study was a controlled trial, which showed limited evidence for seasonal 
influenza infection reduction among GPs through vaccination. The second, an experimental study, 
performed a virus screening on toys in the waiting area before and after disinfection. No study on 
protection measures was found that assessed the impact on influenza transmission in general practices.
Conclusion: The evidence is scarce on interventions that reduce influenza transmission in GP practices.
How this fits in
There is currently insufficient evidence that staff vaccination or use of non-pharmaceutical protective 
interventions (NPIs) decrease seasonal influenza transmission in GP practices. More generally, there 
are limited data on the circulation and transmission patterns of influenza in GP practices. There is 
a need to better assess this, as well as to study preventive and protective measures specifically in 
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GP practices, in order to make clear and adequate recommendations for this specific setting. In the 
meantime, it seems wise to recommend vaccination of staff and additional protective measures for 
healthcare workers (HCWs), by extrapolation from other healthcare settings.
Introduction
Seasonal influenza is a potentially serious illness and is responsible for an important part of the burden 
of infectious diseases worldwide.1,2
The three (non-mutually exclusive) transmission routes for influenza are aerosols, droplets, and direct 
contact.3–5 All three transmission routes are present in the GP practice; for example, through close 
contact in the waiting area, desk surfaces, and the sharing of magazines with viral contamination.3,5,6 
NPIs are of particular interest in cases of high-risk individuals responding poorly to vaccination or 
with contraindication to vaccination, or when vaccination coverage is unknown, such as in the waiting 
room.7 HCWs in practices often use NPIs as protective measures during the influenza season, including 
masks, disinfectant hand gel dispensers, disinfectant wipes, surface disinfection, or social distancing 
through isolation of ill patients.8
Influenza virus persistence on commonly-used equipment or desks is an important target for 
controlling viral transmission by contact.3 Many disinfection substances are proven for neutralising 
influenza virus on surfaces, but none has been specifically tested in practices.9–11 Furthermore, 
environmental factors, such as humidity and temperature, as well as individual factors, like aerosol 
production, may influence the transmission of influenza.4
HCWs are especially at risk for seasonal influenza infection.12 The relative risk ratio (RR) for 
unvaccinated HCWs to be infected is estimated to be three to four times higher than for comparable 
vaccinated adults.13 HCWs build up a high basic immunity and therefore more often have pauci- or 
asymptomatic seasonal influenza compared to their patients, making them more likely to transmit the 
disease.3,13 Some studies have demonstrated that influenza transmission can be reduced in hospitals, 
institutions, and in the community by preventive and protective measures, depending on the 
adherence rates to these measures.12,14 However, a Cochrane review showed no conclusive evidence 
for vaccinating HCWs to prevent seasonal influenza and its complications (lower respiratory tract 
infections [RTIs], hospitalisation, or death due to lower RTIs), or to reduce all-cause mortality in older 
people living in care institutions.15 Preventive measures are interventions before the illness appears 
and protective measures are interventions during the illness appearance. (Box 1)
GPs are often the first medical contact for patients with RTIs and only a minority of patients need 
hospital care.12 Thus, GPs have a central and specific role to play in the prevention of influenza.17 
Classification Term Definition
Prevention Prevention has the goal of decreasing the impact of a predictable 
phenomenon. The prevention occurs before the problem appears.
Prevention refers to measures and actions taken by an individual or a society 
to prevent disease happening or its consequences. In general, prevention 
includes a wide range of interventions aimed at reducing risks to health.
General General prevention, applied before the problem appears, reduces the risk of a 
specific group being affected by a phenomenon.
Personal Personal prevention, applied before the problem appears, reduces the 
personal risk of being affected, at the time of real exposure.
Protection Protection has the goal of decreasing the impact of the phenomenon, but 
only comes into operation when the event is taking place. The protection is, in 
general, a physical intervention. The exposure to the event is reduced through 
the intervention.
General General protection provides protection to the whole population in the same 
room or environment in which the protection measure is placed.
Personal Personal protection provides a physical protection against an actual, real, 
existing phenomenon.
Box 1 Operational definitions16
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Furthermore, HCWs in practices have many short periods of contact with patients with influenza-like 
illnesses during consultation or at the front desk, making this setting distinct from hospitals or the 
community.13
Most studies investigating the impact of preventive and protective measures are performed in 
hospital settings and results are extrapolated to other settings, such as general practices, without 
considering the potential difference in patterns of influenza transmission. Furthermore, most 
randomised-control trials (RCTs) are performed in ideal research conditions; the effectiveness of these 
interventions in day-to-day practice may therefore be questioned.
The present study aims to systematically review the literature on the evidence of the effectiveness 
of preventive and protective measures to reduce the transmission of seasonal influenza in practices.
Method
A systematic literature review was performed of studies assessing preventative and protective measures 
targeting influenza transmission within practices. The MeSH terms (Medical Subject Headings of the 
US National Library of Medicine) used are listed in Box 2. The inclusion and exclusion criteria are 
detailed in Box 3.
All studies performed in adult and older populations that considered protective and preventive 
measures with a direct impact on transmission of seasonal influenza and influenza-like illnesses in the 
Influenza and prevention in primary care
A Influenza MeSH terms: ‘Human Influenza‘ [MeSH] OR ‘Influenza virus‘ [MeSH] OR ‘Influenza A 
Virus‘ [MeSH] OR ‘Influenza B Virus‘ [MeSH] OR ‘Influenza H1N1‘ [MeSH] OR ‘Influenza 
H2N3‘ [MeSH]
Natural wording: flu
B Prevention MeSH terms: ‘Prevention‘ [MeSH] OR ‘Vaccination‘ [MeSH] OR ‘Vaccine‘ [MeSH] OR 
‘Immunisation‘ [MeSH] OR ‘Pharmaceutical Prophylaxis’ [MeSH] OR ‘Pharmaceutical 
Prevention‘ [MeSH] OR ‘Preventive Neuraminidase Inhibitor‘ [MeSH] OR 
‘Complementary Medicine‘ [MeSH] OR ‘Hand Hygiene‘ [MeSH] OR ‘Hand Disinfection‘ 
[MeSH] OR ‘Isolation‘ [MeSH] OR ‘Administration Control‘ [MeSH]
Natural wording: Neuraminidase inhibitor OR antiviral agents OR hand washing OR 
hand sanitizer OR patient isolation OR quarantine OR social distancing OR school 
closure OR inhalation of steam OR vapour inhalation OR humidified air OR sport OR 
exercise OR vitamin C OR vitamin D OR vitamin E OR tobacco cessation OR ginseng OR 
green tea OR echinacea purpurea OR meditation or hydrotherapy OR sea buckthorn 
berries OR gargling OR virucidal handkerchief
C Primary care MeSH terms: ‘Primary Care‘ [MeSH] OR ‘General Medicine‘ [MeSH] OR ‘General 
Practitioner‘ [MeSH] OR ‘Family Medicine‘ [MeSH] OR ‘Ambulatory Care‘ [MeSH] OR 
‘Community Medicine’ [MeSH] OR ‘Family Physician‘ [MeSH]
Natural wording: PC OR family doctor OR PCP OR general practitioner office
Influenza and protection in primary care
Influenza MeSH terms: ‘Human Influenza’ [MeSH] OR ‘Influenza virus’ [MeSH] OR ‘Influenza A 
Virus’ [MeSH] OR ‘Influenza B Virus’ [MeSH]
Natural wording: flu
Protection MeSH terms: ‘Protection’ [MeSH] OR ‘Personal Protective Equipment’ [MeSH] OR 
‘Protective Devices’ [MeSH] OR ‘Chirurgical Mask’ [MeSH] OR ‘Respirator’ [MeSH] OR 
‘N95 Mask’ [MeSH] OR ‘Respiratory Protective Devices’ [MeSH] OR ‘Gloves’ [MeSH] 
OR ‘Surface Disinfection’ [MeSH] OR ‘Ventilation’ [MeSH] OR ‘Aeration’ [MeSH] OR ‘Air 
Filtering’ [MeSH] OR ‘Negative Pressure Room’ [MeSH] OR ‘Air Disinfection’ [MeSH] OR 
‘Ultraviolet Irradiation’ [MeSH]
Natural wording: PPE OR surface cleaning OR avoidance of handshaking OR blouse OR 
protective clothing OR ultraviolet radiation
Primary care
MeSH terms: ‘Primary Care’ [MeSH] OR ‘General Medicine’ [MeSH] OR ‘General 
Practitioner’ [MeSH] OR ’Family Medicine’ [MeSH] OR ‘Ambulatory Care’ [MeSH] OR 
‘Community Medicine’ [MeSH] OR ‘Family Physician’ [MeSH]
Natural wording: PC OR family doctor OR PCP OR general practitioner office
MeSH = Medical Subject Headings of the US National Library of Medicine.
Box 2 Research strategy: MeSH terms used
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Inclusion criteria
Type of study: randomised controlled trials, quasi-experimental studies, observational studies (like cohorts, 
case-control, and cross-sectional studies), laboratory studies with clinical endpoint, before-and-after studies
Participants: adults and/or older patients
Setting: GP practice
Language: English, French, or German
Abstract: available
Outcome: seasonal influenza infections, influenza-like illness with direct impact on transmission of influenza in 
GP practices, influenza virus transmission to HCW
Exclusion criteria
Type of study: case series, case reports, mathematical modelling, experimental laboratory studies or studies 
with no clinical endpoint (for instance, methods to get higher vaccination rates, such as reminders, postcards, 
etc), expert opinion, studies on the epidemiology of influenza infections (evolution of immunity, means of 
transmission, virus survival on various surfaces, etc). These studies kept for introduction and discussion.
Participants: animals
Setting: laboratory, intensive care unit
Language: not any of English, French, or German
Abstract: not available
Outcome: non-influenza infections (such as, rhinovirus infections), pandemic influenza infections, influenza 
vaccination rates
If the same study was published several times, only the most recent version was included.
Box 3 Inclusion and exclusion criteria
general practice were included in this study. Initial search terms were broader than just ‘GP practice’, 
as the text might not clearly or explicitly mention the practice, resulting in the need for an adapted 
search strategy in order to be confident that all potential interventions were captured. The terms 
‘home care’, ‘institutional’, ‘community’ and ‘hospital setting’ were used.
The authors searched Medline, Embase, and the Cochrane Central Register databases for studies, 
published between January 1960–April 2014, and where at least the abstract was published in English, 
French, or German. An update was performed with the same research criteria, screening studies 
published between May 2014–January 2018. A clinical trial registry (http://www. clinicaltrials. gov/) was 
searched to identify relevant unpublished trials. The reference lists of included studies were screened 
to identify supplementary relevant studies.
In the absence of validated definitions of prevention and protection, the authors developed ad 
hoc definitions based on the World Health Organization’s concepts.16 Box  1 provides the study’s 
operational definitions.
Study selection and data extraction
Two independent reviewers (TK and PS) screened all titles and abstracts of potentially relevant articles 
for eligibility. The the full text of the article was read if the title and abstract review were appropriate 
according to the pre-defined inclusion criteria. Disagreements were resolved after consultation of two 
further reviewers (CC and NS). The study update was performed by the same researchers, using the 
same research method.
PRISMA guidelines from 2009 were used to perform a structured and high quality review.18
Two reviewers (PS and TK) independently assessed the level of evidence of the included studies 
using the Cochrane risk of bias tool for non-randomised studies of interventions (ROBINS-l) and 
the classification system published by the Centre for Evidence Based Medicine of the University of 
Oxford.19–21 Consensus group discussions involving all investigators resolved disagreements between 
the two reviewers.
The following information was extracted for all retained studies: population, setting, type of 
intervention, study design, control group, outcome, and results.22 Separately, the measurable effects 
were extracted, such as odds ratio or relative risk, if possible with the corresponding 95% confidence 
intervals (CI).
Finally, studies were retained describing interventions aimed at reducing the transmission of 
influenza specifically in the practice (GP practice being understood as the working place of GPs and 
potential coworkers such nurses, medical assistants, and administrative staff).
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Figure 1 Flowchart of scoping
Results
The research team identified 5727 citations from an initial screen of publications; 1409 were selected 
from the abstract screening, and an additional 97 studies or reviews were identified after screening 
the references of retrieved articles. Five-hundred and three were retained based on the abstract and 
full article assessment. Figure 1 is a flow diagram describing the selection process.
From the 503 retained studies, only two specifically addressed seasonal influenza transmission 
in practices: one RCT on vaccination effectiveness, by Michiels et al; and one observational study 
about surface disinfection, by Pappas et al.12,23 Out of the excluded 501 studies, 29 were performed 
in practice but with an outcome of vaccination adherence of GPs, or promotion of preventive or 
protective measures for HCWs or their patients in practice. The other 472 excluded studies, also 
assessing preventive or protective measures, were not performed in the general practice setting, but 
rather in hospitals, institutions, or in the community. No study combining prevention and protective 
measures was found. Table  1 presents the details of the two selected studies performed in GP 
practices.
Vaccination
No studies were found that directly tested the impact of vaccinating practice HCWs on influenza 
incidence among patients. Only one RCT measured the effectiveness of seasonal influenza prevention 
among GPs (in Flanders, during the two consecutive influenza seasons: 2002–2004). The quality of the 
study was evaluated as moderate, mainly due to missing data in the intervention group in the second 
wave. In this study, Michiels et al12 compared 177 vaccinated GPs (intervention) with 85 non-vaccinated 
Suter P et al. BJGP Open 2019; DOI: 10.3399/bjgpopen19X101657
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Table 1 Summary of all data extraction results
Study
Type of
intervention Control group Population
Length of 
follow-up ROBINS-I Outcome Effect
Vaccination effectiveness
Michiels et 
al12
Vaccination (TIV):
n = 77 in 2002–
2003;
n = 100 in 2003–
2004
No 
intervention:
n = 45 in 2002–
2003;
n = 40 in 2003–
2004
GPs 
working in 
Flanders
Influenza season 
2002–2003; and 
2003–2004
Moderate SII by swab 
test, RTI, SII 
antibodies (4-fold 
hemagglutination 
inhibition 
antibody titre rise 
(taken once after 
the vaccination 
period but before 
the infection 
period; and taken 
once after the 
infection period)
SII: 8.6% in intervention vs 14.7% in 
control (RR 0.59; 95% CI = 0.28 to 
1.24).
SII for ≤30-year-old GP (OR 0.1; 95% CI 
= 0.01 to 0.75)
RTI: 52.5% in intervention vs 53.3% in 
control (RR 0.98; 95% CI 0.76 to 1.27)
RTI for ≤30-year-old GP (aOR 0.35; 
95% CI = 0.13 to 0.96)
RTI and SII antibody rise: 5.3% in 
intervention vs 18.8% in control (RR 
0.28; 95% CI = 0.10 to 0.75)
RTI and SII and/or SII antibody rise: 
11.6% in intervention vs 26.1% in 
control (RR 0.44; 95% CI = 0.22 to 
0.88)
RTI and SII and/or SII antibody rise for 
≤30-year-old GP: aOR 0.1; 95% CI = 
0.02 to 0.98
Low basic antibodies against SII 
predictive of SII: aOR 0.57; 95% CI = 
0.37 to 0.89
Presence of influenza cases in the 
family predictive of SII: aOR 9.24; 95% 
CI = 2.91 to 29
Surface disinfection
Pappas et 
al23
Samples on 
toys in ‘sick’ 
waiting room 
in GP practice 
before and after 
disinfection, 
samples on toys 
in new toy bag
Samples on 
toys in ‘well’ 
waiting rooms
5-provider 
(4 GPs and 
1 nurse) 
general 
pediatric 
practice in 
northern 
Virginia
Respiratory virus 
season, 5 control 
dates
High Picornavirus; 
influenza A and 
B; RSV
Viral RNA detected on n = 11/52 (21%) 
of toys sampled:
n = 10 picoronavirus, n = 1 influenza B.
Viral RNA detected on n = 3/10 (30%) 
from the new toy bag: n = 6/30 (20%) 
in ‘sick’ waiting room; n = 2/12 (17%) in 
‘well’ waiting room.
Before cleaning the ‘sick’ waiting 
room: n = 6/15 (40%) positive for 
picoronaviral RNA. After cleaning: n = 
4/15 (27%); thus, RNA removed from n 
= 4/6 of the original positive.
RNA was not transferred to the fingers 
of the investigator who handled theses 
toys.
aOR = adjusted odds ratio. CI = confidence intervals. OR = odds ratio. RNA = ribonucleic acid. RR = relative risk. RSV = respiratory synctial virus. RTI = 
respiratory tract infection. SII = seasonal influenza infection. TIV = trivalent influenza vaccination.
GPs (control). Outcomes were the occurrence of RTI and symptomatic swab-confirmed seasonal 
influenza during the influenza season, and four-fold increase in influenza haemagglutination inhibition 
antibody titre (comparing pre-infection period [post-vaccination titres in vaccinated] with after-
infection period). There was no difference in the number of GPs with an RTI between the intervention 
and the control group (RR 0.98, 95% CI = 0.76 to 1.27), and a trend towards protection against 
seasonal influenza infection was observed in the intervention group compared to the control group 
(RR 0.59, 95% CI = 0.28 to 1.24). When comparing only the occurrence of RTI that included a four-
fold influenza hemagglutination inhibition antibody titre, a 72% decrease in infection was observed 
between the intervention and control groups (RR 0.28, 95% CI = 0.10 to 0.75). In multivariate analyses, 
influenza vaccination of GPs aged ≤30 years was effective in preventing RTI, and seasonal influenza 
infection. GPs with a lower basic antibody titre against influenza and GPs with an influenza case in the 
family were more at risk for an episode of swab-positive seasonal influenza.12
Protection
Only one experimental study was found about viral contamination in practice waiting areas; it did not 
study the effectiveness of the intervention on the seasonal influenza infection transmission rate.
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surface disinfection
In the patient waiting areas of one paediatric practice, one experimental study (before-and-after design) 
assessed contamination of toys by respiratory viral ribonucleic acid (RNA) during the respiratory virus 
season from October–March, before and after cleaning with disposable germicidal cloths. The quality 
of the study was evaluated as low. Twelve samples were taken in a ‘well’ waiting area and 30 samples 
in a ‘sick’ waiting area. The samples were taken in October, January, and March, but only the samples 
during the annual influenza epidemic in March were tested for influenza virus. Viral RNA was detected 
on 11/52 (21%) tested toys; only one was an influenza B virus. Fifteen toys were sampled before and 
after cleaning in October. Out of six samples positive for picornavirus, four became negative after 
cleaning, while two negative samples became positive. There is limited evidence, of low quality, that 
cleaning with disposable germicidal wipes eliminated viral RNA from toys.23
combined non-pharmaceutical protection interventions (NPIs)
No studies were found assessing NPIs to specifically reduce the transmission of seasonal influenza in 
practices.
Pharmaceutical prophylaxis
No studies were found assessing prophylactic effect of pharmaceuticals on influenza transmission 
within practices.
Discussion
Summary
This systematic literature review investigated interventions aiming to decrease influenza transmission 
in practices. Only two studies were found that were specifically performed in practices. One study 
investigated the prevention of transmission of seasonal influenza through the vaccination of GPs, and 
the other was an interventional study about surface colonisation through respiratory viruses in waiting 
areas before and after surface disinfection. The study by Michiels et al showed a benefit of vaccinating 
GPs in practices, with a positive influence on seasonal influenza infection and RTI, although only among 
GPs aged ≤30 years.12 Pappas et al’s study about surface colonisation showed a high colonisation of 
toys by respiratory virus in the waiting area, but no impact of cleaning the toys. Overall, there is a lack 
of evidence to support any intervention aiming to decrease influenza transmission in practice.23
Strengths and limitations
This systematic review was strengthened by a predefined search strategy, with a broad initial literature 
search followed by secondary filtering. Many relevant studies were captured by performing an 
additional reference list search.
The study has some limitations. First, definitions for prevention and protection had to be determined 
by the author group, as consensus definitions do not exist in the literature. This might limit the 
generalisability of the results. However, the authors tried to adhere as closely as possible to WHO 
recommendations, and believe that the operational definitions used might be useful and acceptable 
to a larger audience. Second, the wide literature search complicates the selection and interpretation 
of the studies, and the identification of those studies actually performed in general practice, and thus 
it is difficult to make clear statements about what might or might not work in general practices. On 
the other hand, a wide search has the advantage that all possible studied interventions were captured, 
independent of the setting, which thus provides a broad picture of what could be useful in practices. 
It also sheds light on the gaps in knowledge relating specifically to studies performed in this setting 
(that is, in general practices) and those extrapolated from other settings. A further limitation is that 
the research had to be updated a second time.
Comparison with existing literature
Although vaccination of HCWs in practices may be an effective measure to reduce transmission 
of seasonal influenza between patients and HCWs, there are no studies directly assessing its 
effectiveness in this setting. The GP is in constant contact with patients and is, therefore, at special 
risk of transmitting seasonal influenza infection and RTI. Michiels et al showed that vaccinating GPs 
Suter P et al. BJGP Open 2019; DOI: 10.3399/bjgpopen19X101657
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can protect them from contracting seasonal influenza.12 No study showed the influence of the GP or 
their patients’ vaccination status on seasonal influenza transmission in the practice. Several studies 
with high risk of bias were performed in nursing homes where HCWs were vaccinated against seasonal 
influenza. A Cochrane review did not find conclusive evidence in favor of vaccinating HCWs in care 
institutions.15 Indeed, investigating the effectiveness of vaccinating practice staff against seasonal 
influenza transmission is difficult, because symptoms are only expressed several days after infection, 
and it is difficult to conceive of a study design that would disentangle transmission in practice from that 
elsewhere in the community. Indeed, vaccinating patients against seasonal influenza in the practice, 
with trivalent or quadrivalent vaccination, may protect patients from seasonal influenza infection, but 
in this case transmission most likely occurs in the community.24,25
NPIs are implemented in the GP setting even though no study showed any real impact on RTI 
transmission in the practice. Pappas et al demonstrated the colonisation of toys in a waiting area 
with different respiratory infection viruses and a positive influence of cleaning the toys, but direct 
transmission to individuals handling the toys was not demonstrated.23 NPIs are mainly effective if used 
in combination.26 Again, as for vaccination, the effectiveness of most NPIs was mainly assessed in 
community settings and not in practices.26 For example, a significant risk reduction of RTI, influenza-like 
illness, or seasonal influenza was observed in studies that assessed seasonal influenza transmission in 
interventions combining mask use and hand hygiene in a community setting.26–28 A tendency towards 
reduction in seasonal influenza infection, and hospitalisation due to seasonal influenza infection, was 
observed with proper hand hygiene.28
In addition, interventions are only effective when they are used by a high number of HCWs and 
patients. Unfortunately, most studies confirm a low vaccination coverage against seasonal influenza 
infection (of 30.2%–81.3%) among GPs and HCWs, which could contribute to the transmission of 
seasonal influenza in the practice.29–33 Interventions such as vaccination promotion programmes, email 
reminders, or free vaccination programmes may improve vaccination coverage of general practice 
workers.34,35 The main barriers to vaccination identified in general practice HCWs were lack of awareness 
of vaccination recommendations and belief of low risk of contracting seasonal influenza.31–33 Patient 
seasonal influenza vaccination is higher if physicians are themselves vaccinated and when the patient 
consults more often, in addition to external factors such as media campaigns.30,33,36,37 However, there 
is currently no evidence directly linking vaccination coverage of the HCWs in general practice or of 
their patients with a decrease in seasonal influenza transmission in practice.
Similarly, combined NPIs are well investigated and implemented in hospital, institutional, 
and community settings, showing a tendency towards reduction of seasonal influenza infection 
and influenza-like illness transmission from HCWs to patients, but studies in general practices are 
missing.27,28 Promotion of NPI use positively influences the habits of HCWs, resulting in an increase 
in their use.8,14,35 Actual recommendations are based on extrapolation and it seems reasonable to 
recommend that GPs use NPIs, even though no studies were performed in GP practices.
Recommendations to reduce seasonal influenza transmission in practices are usually derived from 
other settings, such as hospitals or institutions, as in the case of the UK flu plan 2017/18, which 
recommends strict vaccination coverage for eligible patients and practice HCWs, as well as adapted 
respiratory and hand hygiene.38 Despite this, practices are different from hospitals and institutions 
in many aspects.39 Practices probably concentrate more people with influenza-like illness symptoms 
in close proximity, such as in the waiting area. For these reasons, extrapolating results from other 
settings to the practice might be quite hazardous. But, at present, it is the only means by which to 
make recommendations for the GP setting.
Implications for research
Good quality studies about seasonal influenza transmission in general practices are lacking, both 
for prevention by vaccination and chemoprophylaxis, as well as possible combined effect with NPIs. 
In addition, most of the few existing studies use non-uniform definitions of influenza-like illness, 
non-uniform methods of detection of seasonal influenza infection, or inconsistent testing protocols, 
thereby impeding a proper comparison and interpretation of the studies. Good quality interventional 
studies are needed to provide evidence for the existing recommendations.
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